NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.52
0.02 (0.60%)
At close: Aug 20, 2025, 10:13 AM
0.60% (1D)
| Bid | 2.47 |
| Market Cap | 49.07M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -24.11M |
| EPS (ttm) | -2.21 |
| PE Ratio (ttm) | -1.14 |
| Forward PE | 3.15 |
| Analyst | Buy |
| Ask | 2.56 |
| Volume | 111,735 |
| Avg. Volume (20D) | 285,866 |
| Open | 2.83 |
| Previous Close | 2.50 |
| Day's Range | 2.40 - 2.83 |
| 52-Week Range | 1.10 - 6.01 |
| Beta | 3.50 |
About NRXP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRXP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
NRx Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 13, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+24.56%
NRx Pharmaceuticals shares are trading higher afte...
Unlock content with
Pro Subscription
7 months ago
+30.48%
NRX Pharmaceuticals shares are trading higher after the company announced it will acquire Dura Medical with HOPE Therapeutics. Additionally, the company signed a binding term sheet with HOPE with $27 million to fund further acquisitions and pharmaceutical operations.
2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Makes New Investment in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)Squarepoint Ops LLC purchased a new position in NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchang...